# Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial

Study · id `cardio:ct-nct06429384` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06429384](<https://clinicaltrials.gov/study/NCT06429384>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06429384

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

## Technical summary

Registry record NCT06429384. Randomized; quadruple masking; primary purpose treatment. Start 2023-06-04 (actual); primary completion 2023-11-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 240 participants (enrolled count; ClinicalTrials.gov record NCT06429384, source copy `cardio:ctgov-nct06429384-2024-06-04`, retrieved 2026-10-26)
- Started: 2023-06-04 (actual) (ClinicalTrials.gov record NCT06429384, source copy `cardio:ctgov-nct06429384-2024-06-04`, retrieved 2026-10-26)
- Primary completion: 2023-11-18 (actual) (ClinicalTrials.gov record NCT06429384, source copy `cardio:ctgov-nct06429384-2024-06-04`, retrieved 2026-10-26)
- Completion: 2023-12-24 (actual) (ClinicalTrials.gov record NCT06429384, source copy `cardio:ctgov-nct06429384-2024-06-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06429384, source copy `cardio:ctgov-nct06429384-2024-06-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06429384-2024-06-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Y-3 Injection/Y-3 blank injection
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER
- Collaborator: Neurodawn Pharmaceutical Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)
- Registry lists this organization as a collaborator: Neurodawn Pharmaceutical Co., Ltd. (`cardio:org-neurodawn-pharmaceutical-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial (`cardio:pubmed-41218852`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3fbc843554807e6c729788b6200742374b2242f2de462046d664f2db91e143e4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
